Cambodia vs Rwanda: Average cost of multi drug-resistant tuberculosis treatment
Cambodia
850 constant 2022 US$
in 2024
Rwanda
876 constant 2022 US$
in 2024
Cambodia rank
58th
Rwanda rank
56th
Average cost of multi drug-resistant tuberculosis treatment over time
- Cambodia
- Rwanda
How they compare
Rwanda currently reports 876 constant 2022 US$ against 850 constant 2022 US$ in Cambodia, a difference of 26 constant 2022 US$.
The two have swapped places 1 time across 7 shared years of data; in 2017 it was Cambodia ahead.
Cambodia ranks 58th and Rwanda ranks 56th of 92 countries.
Cambodia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cambodia | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2,247 constant 2022 US$ | 1,084 constant 2022 US$ | 1,163 constant 2022 US$ | Cambodia |
| 2020s | 1,688 constant 2022 US$ | 965.5 constant 2022 US$ | 722 constant 2022 US$ | Cambodia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of multi drug-resistant tuberculosis treatment, Cambodia or Rwanda?
- Rwanda, at 876 constant 2022 US$ against 850 constant 2022 US$ in Cambodia as of 2024.
- What is the difference in average cost of multi drug-resistant tuberculosis treatment between Cambodia and Rwanda?
- 26 constant 2022 US$, with Rwanda ahead.
- How many years of comparable data are there for Cambodia and Rwanda?
- 7 years are reported by both, from 2017 to 2024.
- How do Cambodia and Rwanda rank globally for average cost of multi drug-resistant tuberculosis treatment?
- Cambodia ranks 58th and Rwanda ranks 56th of 92 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of multi drug-resistant tuberculosis treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.